(Q36134190)

12 August 2017

1 reference

title

Quality of life in survivors of testicular cancer (English)

1 reference

12 August 2017

1 reference

Arnstein Mykletun

2

0 references

Sophie D. Fosså

series ordinal

3

object named as

Sophie D Fosså

1 reference

12 August 2017

Alv A Dahl

1

1 reference

12 August 2017

1 May 2005

1 reference

12 August 2017

1 reference

12 August 2017

23

1 reference

12 August 2017

3

1 reference

12 August 2017

193-200

1 reference

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Subjective quality of life and sexual functioning after germ-cell tumour therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Quality of life of survivors of testicular germ cell cancer: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Quality-of-life issues in the treatment of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Long-term side effects of treatment for testis cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Treatment-Associated Leukemia Following Testicular Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Endocrine and exocrine profiles of men with testicular tumors before orchiectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

The treatment of ejaculation disorders after retroperitoneal lymph node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Long-term somatic side-effects and morbidity in testicular cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Long-term effects of chemotherapy in patients with testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Asymmetrical autonomic dysfunction of the feet after retroperitoneal surgery in patients with testicular cancer: 2 case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Radiotherapy for stages I and IIA/B testicular seminoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

The effects of abdominal irradiation for seminoma of the testis on gastrointestinal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

The association between anxiety, depression, and somatic symptoms in a large population: the HUNT-II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Long-term medical care of testicular cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Quality of life after treatment for testicular cancer--the patient's view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Are anxiety and depression related to gastrointestinal symptoms in the general population?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual and marital relationships after treatment for nonseminomatous testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Curative testis cancer therapy: psychosocial sequelae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Long-term effects of testicular cancer on sexual functioning in married couples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Quality of life and stress response symptoms in long-term and recent spouses of testicular cancer survivors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Evaluation of sexual life after orchidectomy followed by radiotherapy for early-stage seminoma of the testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Testicular cancer in young Norwegians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Psychosocial well-being in testicular cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Psychosocial adjustment after testicular cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual dysfunction after treatment for testicular cancer: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Treatment outcome, body image, and sexual functioning after orchiectomy and radiotherapy for Stage I-II testicular seminoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual morbidity following radiotherapy for germ cell tumours of the testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Objective and subjective effects of treatment for testicular cancer on sexual function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual dysfunction in the United States: prevalence and predictors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual disabilities are not singularities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Sexual and marital counseling with men treated for testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Adaptive behavioral responses to potential infertility among survivors of testis cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Impact of Event Scale: psychometric properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Study of anxiety disorder and depression in long-term survivors of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

A brief male sexual function inventory for urology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

Fantasies and facts of the testes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.03.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2005.03.004

1 reference

12 August 2017

1 reference

PubMed ID

15907721